Your browser doesn't support javascript.
loading
High growth rate of benign thyroid nodules bearing RET/PTC rearrangements.
Sapio, Maria Rosaria; Guerra, Anna; Marotta, Vincenzo; Campanile, Elisabetta; Formisano, Raffaele; Deandrea, Maurilio; Motta, Manuela; Limone, Paolo Piero; Fenzi, Gianfranco; Rossi, Guido; Vitale, Mario.
Afiliação
  • Sapio MR; Department of Endocrinologia ed Oncologia Molecolare e Clinica, Università di Napoli Federico II, Via S. Pansini, 5, 80131 Naples, Italy.
J Clin Endocrinol Metab ; 96(6): E916-9, 2011 Jun.
Article em En | MEDLINE | ID: mdl-21411555
ABSTRACT
CONTEXT Benign thyroid nodules display a broad range of behaviors from a stationary size to a progressive growth. The RET/PTC oncogene has been documented in a fraction of benign thyroid nodules, besides papillary thyroid carcinomas, and it might therefore influence their growth.

OBJECTIVE:

The aim of the present work was to evaluate whether RET/PTC in benign thyroid nodules associates with a different nodular growth rate. STUDY

DESIGN:

In this prospective multicentric study, 125 subjects with benign nodules were included. RET rearrangements were analyzed in cytology samples; clinical and ultrasonographic nodule characteristics were assessed at the start and at the end of the study.

RESULTS:

RET/PTC was present in 19 nodules. The difference between the mean baseline nodular volume of the RET/PTC- and RET/PTC+ nodules was not significant. After 36 months of follow-up, the RET/PTC+ group (n = 16) reached a volume higher than the RET/PTC- group (n = 90) (5.04 ± 2.67 vs. 3.04 ± 2.26 ml; P = 0.0028). We calculated the monthly change of nodule volumes as a percentage of baseline. After a mean follow-up of 36.6 months, the monthly volume increase of nodules bearing a RET rearrangement was 4.3-fold that of nodules with wild-type RET (1.83 ± 1.2 vs. 0.43 ± 1.0% of baseline volume; P < 0.0001).

CONCLUSIONS:

Benign thyroid nodules bearing RET rearrangements grow more rapidly than those with wild-type RET. Searching for RET rearrangements in benign thyroid nodules might be useful to the clinician in choosing the more appropriate and timely therapeutic option.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rearranjo Gênico / Nódulo da Glândula Tireoide / Proteínas Proto-Oncogênicas c-ret Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2011 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rearranjo Gênico / Nódulo da Glândula Tireoide / Proteínas Proto-Oncogênicas c-ret Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2011 Tipo de documento: Article País de afiliação: Itália